Literature DB >> 6809519

Effect of cimetidine o endocrine functions--prolactin.

A Hayakawa, S Nishihara, H Ohma, T Misawa.   

Abstract

Effects of cimetidine on the endocrine function were examined in 16 human subjects, i.e. 6 healthy adult volunteers, and each 5 male and female gastro-duodenal ulcer patients. They were all subjected to the examination on the fluctuation of prolactin (PRL) after one-shot intravenous injection of cimetidine. The peptic ulcer patients were orally given 800 mg/day of cimetidine for further 4 weeks. PRL, gonadotropins and sex hormones were determined in the male patients, and only PRL in the females patients. TRH-load test was carried out in all the ulcer patients before and after the administration of cimetidine. The results are shown below: 1) After one-shot intravenous administration of cimetidine 200 mg, serum-PRL significantly increased, the peak level, however, being within normal value range. The increase in PRL was transient, and recovered to the pretreatment value in 60-180 minutes after the administration. 2) During and after the repeated oral administration of 800 mg/day of cimetidine for the consecutive 28 days, serum PRL level did not significantly change. Neither was noted any influence on gonadotropin (LH, FSH) nor sex hormones (estradiol, testosterone) secretion. 3) PRL secretory functions at 500 microgram TRH loading were similar before and after oral administration of cimetidine, without difference in the reactivity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6809519     DOI: 10.1007/BF02774548

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  6 in total

1.  Letter: Breast changes in males on cimetidine.

Authors:  W H Hall
Journal:  N Engl J Med       Date:  1976-10-07       Impact factor: 91.245

2.  Gynaecomastia with cimetidine.

Authors:  G F Delle Fave; G Tamburrano; L De Magistris; C Natoli; M L Santoro; R Carratu; A Torsoli
Journal:  Lancet       Date:  1977-06-18       Impact factor: 79.321

3.  In vitro supersensitivity of the anterior pituitary to dopamine inhibition of prolactin secretion.

Authors:  C Y Cheung; R I Weiner
Journal:  Endocrinology       Date:  1978-05       Impact factor: 4.736

4.  Effects of cimetidine on prolactin, LH, and sex steroid secretion in male and female volunteers.

Authors:  H G Bohnet; M Greiwe; J P Hanker; C Aragona; H P Schneider
Journal:  Acta Endocrinol (Copenh)       Date:  1978-07

5.  Cimetidine postmarket outpatient surveillance program. Interim report on phase I.

Authors:  L M Gifford; M E Aeugle; R M Myerson; P J Tannenbaum
Journal:  JAMA       Date:  1980-04-18       Impact factor: 56.272

6.  Hypothalamic-pituitary-gonadal dysfunction in men using cimetidine.

Authors:  D H Van Thiel; J S Gavaler; W I Smith; G Paul
Journal:  N Engl J Med       Date:  1979-05-03       Impact factor: 91.245

  6 in total
  2 in total

Review 1.  Famotidine. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  H D Langtry; S M Grant; K L Goa
Journal:  Drugs       Date:  1989-10       Impact factor: 9.546

Review 2.  Famotidine. Pharmacodynamic and pharmacokinetic properties and a preliminary review of its therapeutic use in peptic ulcer disease and Zollinger-Ellison syndrome.

Authors:  D M Campoli-Richards; S P Clissold
Journal:  Drugs       Date:  1986-09       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.